Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases (NDs) such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) are devastating conditions that can develop without noticeable symptoms, causing irreversible damage to neurons before any signs become clinically evident. NDs are a major cause of disability and mortality worldwide. Currently, there are no cures or treatments to halt their progression. Therefore, the development of early detection methods is urgently needed to delay neuronal loss as soon as possible. Despite advancements in Medtech, the early diagnosis of NDs remains a challenge at the intersection of medical, IT, and regulatory fields. Thus, this review explores “digital biomarkers” (tools designed for remote neurocognitive data collection and AI analysis) as a potential solution. The review summarizes that recent studies combining AI with digital biomarkers suggest the possibility of identifying pre-symptomatic indicators of NDs. For instance, research utilizing convolutional neural networks for eye tracking has achieved significant diagnostic accuracies. ROC-AUC scores reached up to 0.88, indicating high model performance in differentiating between PD patients and healthy controls. Similarly, advancements in facial expression analysis through tools have demonstrated significant potential in detecting emotional changes in ND patients, with some models reaching an accuracy of 0.89 and a precision of 0.85. This review follows a structured approach to article selection, starting with a comprehensive database search and culminating in a rigorous quality assessment and meaning for NDs of the different methods. The process is visualized in 10 tables with 54 parameters describing different approaches and their consequences for understanding various mechanisms in ND changes. However, these methods also face challenges related to data accuracy and privacy concerns. To address these issues, this review proposes strategies that emphasize the need for rigorous validation and rapid integration into clinical practice. Such integration could transform ND diagnostics, making early detection tools more cost-effective and globally accessible. In conclusion, this review underscores the urgent need to incorporate validated digital health tools into mainstream medical practice. This integration could indicate a new era in the early diagnosis of neurodegenerative diseases, potentially altering the trajectory of these conditions for millions worldwide. Thus, by highlighting specific and statistically significant findings, this review demonstrates the current progress in this field and the potential impact of these advancements on the global management of NDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Growing access to speech data through mobile platforms, telehealth, and ambient voice technology is accelerating progress in this domain.105,106”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On computable numbers, with an application to the entscheidungsproblem
Turing, A. M. (1937) · Proceedings of the London Mathematical Society · doi:10.1112/plms/s2-42.1.230 · Cited by 8,283
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Pawlak, Z. (1991) · Springer eBooks · doi:10.1007/978-94-011-3534-4 · Cited by 3,040 · cited 1×
“Introduced by Pawlak (1982), the RST offers a framework for understanding how the brain processes complex visual information, despite the imprecise nature of concepts representing objects’ physical properties [114,115].”
BackgroundEye Tracking Methodology: Theory and Practice
Duchowski, A. T. (2003) · Springer eBooks · doi:10.1007/978-1-4471-3750-4 · Cited by 2,242
Openface 2.0: facial behavior analysis toolkit
Baltrusaitis, T., Zadeh, A., Lim, Y. C., & Morency, L.-P. (2018) · 2018 13th IEEE International Conference on Automatic Face & Gesture Recognition (FG 2018) · doi:10.1109/fg.2018.00019 · Cited by 1,861 · cited 1×
“Importantly, mature open-source projects like OpenFace provide state-of-the-art results for selected facial action unit (AU) recognition [54].”
BackgroundAlzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,181
The SAGE Encyclopedia of Communication Research Methods
Allen, M. (2017) · doi:10.4135/9781483381411 · Cited by 1,103
The Parkinson Pandemic—A Call to Action
Dorsey, E. R., & Bloem, B. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3299 · Cited by 1,091 · cited 1×
“This is due to a combination of factors, including an aging population, declining smoking rates, and increasing industrialization [11,12].”
BackgroundZadeh, L. A. (1999) · IEEE Transactions on Circuits and Systems I: Fundamental Theory and Applications · doi:10.1109/81.739259 · Cited by 1,039
Adult hippocampal neurogenesis and its role in Alzheimer’s disease
Mu, Y., & Gage, F. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-85 · Cited by 1,021 · cited 1×
“Changes in the hippocampus, including altered neurogenesis, are early events in AD and may worsen memory impairment [26].”
Background
Research works printed but not linked: 2
- 38. Bejani, M.; Luque-Buzo, E.; Gomez-García, J.; Burlaka-Petrash, A.; Grandas, F.; Godino-Llorente, J. Detection of Parkinson's Disease by Analysis of Smooth Pursuit Eye Movements and Machine Learning. Mov. Disord. 2023, 37 (Suppl. S2), S184-S185. Available online: https://www.mdsabstracts.org/abstract/detection-of-parkinsons-disease-by-analysis-of-smooth-pursuit- eye-movements-and-machine-learning/ (accessed on 21 December 2023).
- Pawlak, 1982, Rough sets, Int. J. Parallel Program., 11, 341
Cited by
Items 101–151 of 151
Machine Learning Methods for Parkinson’s Disease Datasets
Chudzik, A., & Przybyszewski, A. W. (2025) · Studies in computational intelligence · doi:10.1007/978-981-96-5585-4_6
Self-citationIlegomah, A., & Ighodaro, O. M. (2025) · Preprints.org · doi:10.20944/preprints202508.1370.v1
González-Cabrero, J., Gómez, C., & Cavas, F. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109089
Zhao, Q., Xiao, Q., Chen, Y., Yang, M., Dai, L., Xiong, Y., & Yue, J. (2025) · Bioengineering · doi:10.3390/bioengineering12111143
New Developments in Nutritional Neuroscience in the Age of Digitalization
Yıldırım, İ. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1983-5_6
Biomarkers to Personalized Therapies in Neurodegenerative Medicine
Shaik, A., Shevate, K. S., Fanai, H. L., & Chand, J. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_17
Towards automated analysis of gaze behavior from consumer VR devices for neurological diagnosis
Schmitz, L., Plack, M., Klein, R., Lähner, Z., Dröge, H., Koyak, B., Ullah, M. E., & Aziz, N. A. (2025) · doi:10.7490/f1000research.1120287.1
RECENT ADVANCES IN SMALL-MOLECULE THERAPEUTICS TARGETING NEUROINFLAMMATION
Rahimoff, R., & Nesic, M. (2025) · Medicinal chemistry reviews · doi:10.1021/mc-2025-vol60.ch05
Discriminating and Measuring Activities of Daily Living
Newman, J. L., Collins, J., & Phillips, J. S. (2025) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc58623.2025.11251699
“Early diagnosis of diseases such as Parkinson’s and Alzheimer’s Disease enables access to treatments which may reduce symptom severity [2], and which may eventually allow the progress of these degenerative diseases to be delayed [3].”
Alzheimer's disease detection based on MR images using the quad convolutional layers CNN approach
Pamungkas, Y., Syaifudin, A., Yunanto, W., & Hashim, U. (2025) · Bulletin of Electrical Engineering and Informatics · doi:10.11591/eei.v14i6.10304
“Meanwhile, contrast augmentation is used to enhance the visibility of brain structures by accentuating the intensity distinction between gray and white matter, which helps the model focus more on discriminating Non-Dementia from Dementia across varying severity grades [20].”
Terveysteknologian mahdollisuudet Alzheimerin taudin varhaisessa tunnistamisessa
Haverinen, E. (2025) · Theseus (Ammattikorkeakoulujen)
Phenotyping Behavioral Disorders in REM Sleep: Study of Digital Biomarkers of Neurodegeneration
Sattar, P. (n.d.) · UNICA IRIS Institutional Research Information System (University of Cagliari)
Abiri, E., & Raesi, R. (2025) · Archives of Advances in Biosciences · doi:10.22037/aab.v16i1.50780
Esmaeel, T. H. M., Obid, Z. K. H., Ali, M. G. F., & Ibrahim, G. B. T. (2025) · EJSMT · doi:10.59324/ejsmt.2025.1(6).21
Bengesi, S., El-Sayed, H., & Sarker, M. K. (2026) · Smart innovation, systems and technologies · doi:10.1007/978-981-95-1353-6_17
Li, S., Chen, Y., Xu, J., Zhang, J., & Yang, Y. (2025) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2025.630.644
“In parallel, (Chudzik et al., 2024) shown that machine learning and digital biomarkers can detect early stages of neurodegenerative disorders like Alzheimer's, allowing for timely intervention.”
Ramkumar, G., Sheema, S., Reddy, B. A., Khresat, O., Muralikrishna, C., & A.Subashree (2025) · International Conference on Science Technology Engineering and Mathematics (ICONSTEM) · doi:10.1109/iconstem65670.2025.11374748
“In [18], the capabilities of AI-driven digital biomarkers, including eye tracking and facial expression analysis, for the early detection of neurodegenerative diseases such as Alzheimer’s and Parkinson’s are emphasized, underscoring their diagnostic accuracy.”
Lee, Y., Son, H. G., & Byun, J. (2026) · JMIR Formative Research · doi:10.2196/87928
“The expansion of digital health technologies, particularly smartphone apps and wearable devices such as smartwatches and smart rings, has created new possibilities for personalized and remote patient care [10-13].”
Dubey, P., Upadhyayula, J. P., Mallik, B., Packirisamy, G., & Brako, F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40441-2.00007-x
Future perspectives: Toward universal early detection of chronic diseases
Hooshmandi, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33263-0.00005-x
The neurological weather forecast: predicting cognitive storms before they arise
Kumar, N., Devi, K., Sharma, S. K., Saini, V., Singh, A., Dey, S., & Singh, K. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44025-0.00012-7
Sedhupathy, P., Arumugam, S., Chanu, T. K., Nithya, M., Shanmugasundaram, R. S., Selvaraj, A., & Sharma, S. (2026) · Genetics and Molecular Research · doi:10.4238/3r8zn256
DECAF: Dual-Domain Evidential Cross-Attention Fusion Network for MRI-Based Cognitive Decline Staging
Khan, A., Bushara, A. R., Ashraf, B. M., Raj, N., & A, M. S. M. (2026) · International Conference on Innovative Trends in Information Technology (ICITIIT) · doi:10.1109/icitiit68860.2026.11499486
“Integrating multimodal sensor data such as speech, gait, and neuroimaging with machine learning enables accurate, noninvasive early detection of neurodegenerative diseases like Alzheimer’s and Parkinson’s, supporting scalable AI-driven diagnostic solutions [1].”
Detection of Alzheimer’s Disease Using Machine Learning and Biosensor Integration
Dutta, A. K., Unhelkar, B., Shankar, S. S., Gupta, D., & Alzahrani, M. G. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-21499-7_34
Specialized neurological assessment techniques
Verma, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33855-7.00004-8
USO DA INTELIGÊNCIA ARTIFICIAL EM DOENÇAS NEURODEGENERATIVAS
Batista, A. H. A., Sampaio, D. M., Santos, L. B. M. D., Macedo, V. L., Araújo, J. T., Campelo, A. R. F., Bezerra, J. H. S., Neto, F. T. D. C., Pedrozo, A. B. L., Vasconcelos, M. D. A., et al. (2026) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2026v8n5p2232-2239
Intelligent Generation Method of Game Character Expressions Based on Deep Learning
Wang, X., & Luo, H. (2026) · Procedia Computer Science · doi:10.1016/j.procs.2026.05.029
Elkhodiry, A. A., Bokhari, S. A., Alagha, N., Mohammed, D., Kakkar, R., Abdalla, A., Copiaco, A., Himeur, Y., Ritz, C., Beheshti, A., et al. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08255-y
“Actigraphy, speech analysis, and eye-tracking are examples of digital markers that have demonstrated potential in identifying early signs and tracking therapeutic outcomes with greater sensitivity and reliability than conventional assessments [23–25].”
Alotaibi, Y. A., & Rajendran, S. (2026) · BMC Psychology · doi:10.1186/s40359-026-05043-x
“The sweep factor ω r,u ∈ [1 , 3] adds a con-trol mechanism for how tightly the hiker should follow the best solution, and factor ξ r,u introduces stochasticity or randomness to prevent premature convergence.”
Practical Application of Biosensors and Case Studies in Neurological Disorder
Gupta, A. K., Mishra, A. K., Kumar, A., Gond, A., Yadav, R., Verma, H., & Prajapati, A. (2026) · PAIN JOINTS SPINE · doi:10.1922/pjs.16.3s.2026.614
Research Advances in Diagnostic Methods for Prevalent Neurological Diseases
Lv, M., Sun, X., & Wang, X. (2026) · Biosensors · doi:10.3390/bios16070368
“They primarily consist of digital data generated through the continuous collection and quantitative analysis of physiological signals using biosensors or portable digital devices [134,135].”
AI Enabled EEG Analysis for Detection of Neurodegenerative Disorders
Saxena, M., KUSHWAHA, R. S., GIRI, R., Kumar, A., Singh, U. P., Singh, S., Singh, P., & Bandyopadhyay, A. (2026) · Studies in Rhythm Engineering · doi:10.1007/978-3-032-20634-3_24
Precision therapeutics and innovative clinical trial design in neurodegenerative diseases
Garcia, A., Delgado-Uriarte, J. C., & Cervantes‐Arriaga, A. (2026) · Revista de investigaci�n Cl�nica · doi:10.1016/j.ric.2026.100050
Bhat, S., & Shetty, S. (2025) · International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC) · doi:10.1109/i-smac65734.2025.11597791
“Integrating eye tracking and facial expressions improves diagnostic accuracy [10].”
Laghai, A. (2026) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2026-17124
Artificial Intelligence Techniques for Stroke Diagnosis: A State-of-the-Art Review
Wen, J., Liu, J., & Li, Y. (2025) · International Conference on Computer Science and Artificial Intelligence Applications (CSAIA) · doi:10.1109/csaia65930.2025.11623813
“…from single-disease diagnosis to comprehensive disease management, providing early warnings and personalized treatment decision support for complex brain disorders [15-16] by integrating multidimensional information including genetic risks [17] and real-time physiological monitoring [18].”
Predicting Alzheimer’s Disease Based on Interpretive Ensemble Learning
Alsaleem, M. Y. A., Hasan, O. S., Albugg, Y., & Mostafa, S. A. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-27666-7_5
Nguyen, L., & Zhan, H. (2026) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi69079.2026.00160
“Broader reviews likewise highlight the growing role of machine learning for integrating complex biomarkers and supporting stratification in translational and neurodegenerative research [7], [8].”
Wang, H., & Zhang, X. (2026) · Digital Health · doi:10.1177/20552076261479403
“43,44 45–47 Yet within the mapped corpus, these approaches remain more descriptive than regulatory: they primarily support cross-sectional stratification and screening, with limited explicit modeling of progression velocity or longitudinal state change.”
Xu, C., Wang, X., Tang, Q., Yang, L., & Li, H. (2026) · IEEE International Conference on Big Data and Artificial Intelligence (BDAI) · doi:10.1109/bdai70753.2026.11655103
“Speech has recently attracted attention as a digital biomarker for neurodegenerative disease because it can be collected remotely, repeatedly, and at low cost [4], [5].”
Emerging drugs for cognitive treatment and enhancement
Lavanya, P. R., Prabhu, P., Singh, I., & Singh, A. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36544-7.00009-4
Chaitanya, K., Reddy, S., Derangula, A., Kumari, D. A., Srikanth, B., & Kumar, K. K. (2026) · International Conference on Modern Sustainable Systems (CMSS) · doi:10.1109/cmss69636.2026.11689043
“The effect of NDs includes the death and atrophy of the brain nerve cells leading to cognitive, motor, memory and behavioural impairments [2].”
AI-enhanced imaging, monitoring, and diagnostics in precision nanomedicine
Suruthi, G. S., Puzhakkal, A., Palanisamy, S. K., Gunasekaran, A., Asirvatham, A. R., Shanmugam, V., Philomenathan, A. P. J., & Arumugam, V. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45321-2.00010-2
Frimpong, K. (2026) · International Journal of Advance Scientific Research
Latha, J. S. (2024) · Journal of Electrical Systems
Özeloğlu, İ. G., & Aydın, E. A. (2026) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2026.2736243
Porwal, M., Malviya, R., Chandra, P., Sridhar, S. B., Shareef, J., Wadhwa, T., & Balusamy, B. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103919
Dryden, D., Gillings, E., Leightley, D., & Murphy, D. (2026) · doi:10.2196/preprints.114317
Arif, S., & Hanif, M. (2026) · Procedia Computer Science · doi:10.1016/j.procs.2026.10.250
Sharma, S., Sontakke, R., & Jain, S. (2026) · Life Science Research Communications · doi:10.5530/lsrc.2.3.25
Ali, S., Arshad, M., Nazakat, L., Zia, S., & Iqbal, H. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00642-x
Metadata
- Authors
- Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W.
- Affiliations
- Polish-Japanese Academy of Information Technology (PL)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Przybyszewski, Andrzej W.
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2024-02-29
- Volume
- 24
- Issue
- 5
- Pages
- 1572
- ISSN
- 1424-8220 (ISSN-L)
- PMC
- PMC10934426
- OpenAlex
- W4392285688
- Cited by
- 122
- References
- 131
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 17
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Sensors (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Life Sciences › Neuroscience › Cognitive Neuroscience › EEG and Brain-Computer Interfaces
- Keywords
- neurodegenerative diseases, early diagnosis, digital biomarkers, Alzheimer's disease, Parkinson's disease, eye tracking, facial expression analysis, convolutional neural networks, presymptomatic detection, data privacy, clinical validation
- MeSH terms
- Machine Learning, Alzheimer Disease, Humans, Parkinson Disease, Biomarkers, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.